George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 153.00
Bid: 146.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 14.00 (9.589%)
Open: 153.00
High: 153.00
Low: 153.00
Prev. Close: 153.00
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Open Offer, GM and Total Voting Rights

22 Feb 2023 12:28

RNS Number : 7408Q
Itaconix PLC
22 February 2023
 

22 February 2023

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS ANNOUNCEMENT SHOULD BE READ IN ITS ENTIRETY.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY NEW ORDINARY SHARES OF THE COMPANY. 

This announcement should be read in conjunction with the full text of the Circular issued on 6 FEBRUARY 2023. All capitalised terms used in this announcement and not otherwise defined shall have the meanings given to them in the Circular.

 

Itaconix plc

 ("Itaconix", the "Company" or the "Group")

Results of Open Offer, General Meeting

and Total Voting Rights

The Board of Itaconix plc, a leading innovator in sustainable plant-based polymers used to decarbonise everyday consumer products, is pleased to announce that it has received valid acceptances from Qualifying Shareholders in respect of 4,513,420 Open Offer Shares. This represents approximately 58.2 per cent. of the 7,760,852 New Ordinary Shares available under the Open Offer.

The Board also announces that at the General Meeting held earlier today, all Resolutions were duly passed by Shareholders.

The Company has therefore raised, in aggregate, gross proceeds of approximately £10.5 million through the Placing, Subscription and Open Offer.

Admission and Total Voting Rights

Application has been made for the 138,563,048 New Ordinary Shares (being the 133,094,856 Conditional Placing Shares, 954,772 Subscription Shares and 4,513,420 Open Offer Shares) to be admitted to trading on AIM. It is expected that the Admission of the Conditional Placing Shares, the Subscription Shares and the Open Offer Shares will occur and dealings in the New Ordinary Shares will commence at 8.00 a.m. on 27 February 2023.

Following Admission, the total number of Ordinary Shares in issue will be 674,306,055. There are no Ordinary Shares held in treasury. Accordingly, the total number of voting rights in the Company on Admission will be 674,306,055. This figure may be used by Shareholders as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

John R. Shaw, CEO of Itaconix, commented:

"We have successfully raised gross proceeds of £10.5 million. I am extremely pleased to welcome new institutional shareholders to the Company. We are now entering a new stage of development as we aim to become a much larger sustainable ingredient company. Our strong balance sheet now gives us the opportunity to target higher revenue growth from our current ingredients. There are a number of exciting opportunities for us to develop new ingredients and increase revenues from our substantial itaconate technology platform. We approach the future with more commercial progress, more resources, more potential, and more optimism than ever before."

 

For further information please contact:

Itaconix plc

+1 603 775 4400

John R. Shaw / Laura Denner

Belvedere Communications

+44 (0) 20 3008 6864

John West / Llew Angus

finnCap

Nominated Adviser & Broker, Bookrunner

+44 (0) 20 7220 0500

Ed Frisby / Abigail Kelly (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

Canaccord Genuity

Co-Lead Manager

+44 (0) 20 7523 8000

Adam James / Sam Lucas (Investment Banking)

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in cleaning, hygiene, and beauty. Itaconix's contributions to the global low carbon economy are recognised by the London Stock Exchange's Green Economy Mark.

www.itaconix.com

The Notification of Dealing Forms set out below are provided in accordance with the requirements of MAR.

1

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

a)

Name

John R. Shaw

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Itaconix plc

b)

LEI

213800OKA3GOCK2ZA496

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

New Ordinary Shares of 1 pence each

Identification code

GB00B84LVH87

b)

Nature of the transaction

Purchase of New Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5.1p

79,564

d)

Aggregated information:

· Aggregated volume

 

· Price

See 4c) above

e)

Date of the transaction

27 February 2023

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

a)

Name

Laura Denner

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Itaconix plc

b)

LEI

213800OKA3GOCK2ZA496

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

New Ordinary Shares of 1 pence each

Identification code

GB00B84LVH87

b)

Nature of the transaction

Purchase of New Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5.1p

79,564

d)

Aggregated information:

· Aggregated volume

 

· Price

See 4c) above

e)

Date of the transaction

27 February 2023

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

a)

Name

Peter Nieuwenhuizen

2.

Reason for the Notification

a)

Position/status

Non-Executive Chair

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Itaconix plc

b)

LEI

213800OKA3GOCK2ZA496

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

New Ordinary Shares of 1 pence each

Identification code

GB00B84LVH87

b)

Nature of the transaction

Purchase of New Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5.1p

795,644

d)

Aggregated information:

· Aggregated volume

 

· Price

See 4c) above

e)

Date of the transaction

27 February 2023

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROIUUAUROAUUUAR
Date   Source Headline
19th Apr 20247:00 amRNSGrants of Options & PDMR dealings
15th Apr 20247:00 amRNSPreliminary Results and Notice of AGM
8th Apr 20247:00 amRNSNotice of Results
2nd Apr 20247:00 amRNSTrading Statement
27th Feb 20247:00 amRNSTrading Update
9th Feb 20247:00 amRNSAppointment of Non-Executive Director
26th Jan 20247:00 amRNSAppointment: Nominated Adviser and Sole Broker
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
30th Oct 20237:00 amRNSDirector/PDMR Shareholding
26th Oct 20235:28 pmRNSDirector/PDMR Shareholding
19th Oct 20235:08 pmRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSDirector/PDMR Shareholding
5th Oct 202311:01 amRNSHoldings in Company
12th Sep 20237:00 amRNSHalf year results
5th Sep 20237:00 amRNSNotice of Interim Results and Presentations
22nd Aug 20237:00 amRNSShare Consolidation & Total Voting Rights
15th Aug 20237:00 amRNSShare Consolidation
12th Jul 20237:00 amRNSTrading Update
28th Jun 202312:29 pmRNSAGM Statement
5th Jun 20237:00 amRNSFinal Results
24th May 20237:00 amRNSNotice of Final Results, Briefings, and AGM
25th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
2nd Mar 20233:25 pmRNSTR-1
1st Mar 20237:00 amRNSAward from Frost & Sullivan
28th Feb 20236:03 pmRNSTR-1
28th Feb 20235:04 pmRNSTR-1
28th Feb 20233:09 pmRNSTR-1
23rd Feb 20237:00 amRNSTR-1
22nd Feb 202312:28 pmRNSResults of Open Offer, GM and Total Voting Rights
15th Feb 20237:00 amRNSInvestor Presentation following GM on 22 Feb 2023
3rd Feb 20237:00 amRNSPlacing, Subscription and Open Offer; Notice of GM
5th Jan 20237:00 amRNSBoard Change
6th Dec 20224:40 pmRNSSecond Price Monitoring Extn
6th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Oct 20227:00 amRNSItaconix and Brenntag Promote Sustainable Cleaning
14th Sep 20227:00 amRNSHalf year results
13th Sep 202211:05 amRNSSecond Price Monitoring Extn
13th Sep 202211:00 amRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSNotice of Results
5th Sep 20227:00 amRNSItaconix and Croda Renew Supply Agreement
20th Jul 20227:00 amRNSBoard Change
13th Jul 20227:00 amRNSTrading Update
5th Jul 20227:00 amRNSDirectorate Change
1st Jul 20222:37 pmRNSResult of AGM
1st Jul 20229:00 amRNSPrice Monitoring Extension
1st Jul 20227:00 amRNSAGM Statement and Notice of Capital Markets Event
29th Jun 20227:00 amRNSNotice of Capital Markets Webinar
8th Jun 20229:04 amRNSFinal Results - replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.